Log in to search using one of your social media accounts:

 

Revolution in individualized treatment of prostate cancer
Dr. Susanne Osanto discusses the emergence of new molecular and genomic protocols to develop personalized therapies for patients both early and advanced stages. Author: vhsimons Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Key Insights: Lymphoma & amp; Myeloma 2017 - CLL
In this activity, Congress Chair Dr. Morton Coleman and CLL Session Co-Chair Dr. Richard R. Furman discuss highlights of the second day of Lymphoma & Myeloma 2017: An International Congress on Hem... Author: imedex Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Key Insights: Lymphoma & Myeloma 2017 - Lymphoma
In this Key Insights activity, Congress Chair Dr. Morton Coleman and Lymphoma Session Co-Chair Dr. John Leonard discuss highlights of the third day of Lymphoma & Myeloma 2017: An International Congre... Author: imedex Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Primary analysis of MURANO study data for R/R CLL
Updates from the highly anticipated Phase III MURANO study (NCT02005471) in relapsed/refractory chronic lymphocytic leukemia (CLL) were presented at the American Society of Hematology (ASH) 2017 Annua... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Key Insights: Lymphoma & Myeloma 2017 - Multiple Myeloma
In this Key Insights activity, Drs. Morton Coleman and Ruben Niesvizky discuss highlights of the first day of Lymphoma & Myeloma 2017: An International Congress on Hematologic Malignancies held in Oc... Author: imedex Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

New nivolumab combination therapies for AML
There has historically been less novel agents being tested and moving into the clinic for AML. Now, there has been a wave of promising trials. Speaking from the American Society of Hematology (ASH) 20... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Exciting novel AML treatment: venetoclax plus cobimetinib or idasanutlin in elderly patients
Venetoclax combinations have shown excellent results in chronic lymphocytic leukemia (CLL), but are now, excitingly, displaying fantastic preliminary outcomes in acute lymphocytic leukemia (ALL). In t... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Investing in nurse development: facilitating communication within and across CNS teams
Although a key skill of nursing is communication with patients and the multidisciplinary team, ensuring good communication channels within and across nursing teams is also essential. Speaking from the... Author: VJOncology Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

UKONS 2017: speaking under time pressure
Nursing is a demanding job, with the many responsibilities and patients meaning that nurses are often under considerable time pressure. Speaking from the UK Oncology Nursing Society (UKONS) Annual Con... Author: VJOncology Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Acute oncology: new immunotherapy guidelines
Immunotherapies can come with a range of toxicities that require the appropriate management by acute oncology services. In this interview, Liz Gifford of the University Hospital Southampton NHS Founda... Author: VJOncology Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Center experience: immunotherapy in Southampton
As novel immunotherapies are introduced into practice, centers need to implement new protocols and educate staff in order to ensure a successful adoption. Speaking from the UK Oncology Nursing Society... Author: VJOncology Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

The rarer toxicities of immunotherapy
Immunotherapies can induce a range of common, as well as rare, side effects. These may be difficult for healthcare professionals to spot if they have not observed them previously. In this interview, L... Author: VJOncology Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

The systemic anti-cancer dataset (SACT): optimizing immunotherapy toxicity management
Collating data and communicating center experiences is essential to ensure that the best standard of care is provided to patients across geographical boundaries. In this interview, Liz Gifford of the ... Author: VJOncology Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Early Use of Chemotherapy for Prostate Cancer?
Dr. Susanne Osanto discusses the use of chemotherapy plus androgen deprivation therapy (ADT) for newly diagnosed men with advanced stage prostate cancer. Author: vhsimons Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Practical intricacies surrounding biosimilar adoption
There are many intricacies surrounding the introduction of biosimilars. Here, Simon Cheesman, BPharm, MRPharmS from University College London Hospital (UCLH), London, UK discusses some of these issues... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

The introduction of biosimilar rituximab: a case study from the pharmacist's perspective
"During the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium for cancer care pharmacy in Glasgow, UK, Simon Cheesman, BPharm, MRPharmS from the University College London Hospita... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

The role of pharmacists for driving the integration of biosimilar monoclonal antibodies into practice
"During the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium for cancer care pharmacy in Glasgow, UK, Simon Cheesman, BPharm, MRPharmS from the University College London Hospita... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

The challenges of cancer research and the critical role of the pharmacist
"Peter Johnson, BA, MB BChir, MA, MRCP, MD, FRCP from Southampton General Hospital, Southampton, UK, summarises the challenges of cancer research during the BOPA 2017 annual symposium in Glasgow... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Advancing cellular therapies for blood cancers
David Irvine from the Beatson Institute, Glasgow, UK outlines his presentation on cellular advances in hematological oncology given at the British Oncology Pharmacy Association (BOPA) 20th Annual Symp... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

The benefits of having academics who work clinically
Having academics who also work in the clinic has a wide range of benefits. In this interview, Naomi Farrington, PhD, of the University Hospital Southampton NHS Foundation Trust, Southampton, UK, empha... Author: VJOncology Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts

The services improving elderly cancer patient care
Elderly cancer patients are likely to have comorbidities and more complex treatment needs, which can result in certain treatments not being offered to them. In order to determine the optimal treatment... Author: VJOncology Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts

Challenges facing elderly cancer patients
Elderly patients comprise the majority of cancer cases; however, they are often overlooked in many facets of oncology research and care. In this interview, Naomi Farrington, PhD, of the University Hos... Author: VJOncology Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts

Increasing role of the pharmacist in patient care
Pharmacists have an excellent knowledge of drugs and are an essential part of the multidisciplinary healthcare team. Excitingly, they are now becoming increasingly involved in the management and care ... Author: VJOncology Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts

Patient education and the role of the nurse
Nurses have a high level of contact with individual patients, which enables them to have a unique perspective on their emotional and practical needs. Speaking from the UK Oncology Nursing Society (UKO... Author: VJOncology Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts

Managing the care of patients receiving oral systemic anti-cancer therapy (SACT)
The official recommendations are that patients taking oral systemic anti-cancer therapy (SACT) receive the same level as care as those receiving intravenous SACT in a hospital setting. However, this p... Author: VJOncology Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts

The importance of research in cancer nursing
The debate at the UK Oncology Nursing Society (UKONS) Annual Conference 2017 in Harrogate, UK, focused on highlighting the importance of different areas of cancer nursing, including research. In this ... Author: VJOncology Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts

Genomic Sequencing for All Solid Tumors: Where Will This Lead Us? (BMIC-019)
Dr. Jack West reviews the implications, both encouraging and potentially detrimental, of a recent FDA approval for broad genomic (NGS) testing of all solid tumors, ushering in a new era of growing pre... Author: BeaconMedIC Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Detecting, Identifying and Treating Subtypes of CLL
CLL is different for every patient, so how do doctors tell which CLL treatment is right? Dr. Kathryn Kolibaba and Dr. Stephen Spurgeon discuss modern tests used to distinguish subtypes of CLL and find... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Does Small Cell Lung Cancer (SCLC) Have Stages?
What are the different stages of small cell lung cancer (SCLC)? Dr. Laura Chow of Seattle Cancer Care Alliance explains how SCLC can progress and the associated stage, the treatment plan, and where re... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Is There Anything I Can Do to Prevent or Slow Progression of My MPN?
Patient Power community member Julie writes, Is there anything that patients can do to prevent or slow MPN progression? Dr. Abdulhareem Yacoub, an MPN expert from the University of Kansas Medical Ce... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Can CLL Treatment Start Earlier?
For some chronic lymphocytic leukemia (CLL) patients, the watch-and-wait period can be unsettling, leaving them wondering why a life-threatening condition hasnt received treatment yet. Why doesnt tr... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Are There Vaccine Recommendations for Patients With MPNs?
In this Ask the Expert segment, a Patient Power community member wants to know Are there recommendations for vaccines for patients with MPNs? Tune in to hear Dr. Abulraheem Yacoub explain the differ... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

NSCLC vs. SCLC: Why Are They Treated Differently?
Dr. Laura Chow of Seattle Cancer Care Alliance explains the different types of lung cancer, their distinctive growth patterns and treatment methods available today.Get email alerts | http://www.pa...... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Can I Have a Good Quality of Life With Small Cell Lung Cancer?
How can small cell lung cancer (SCLC) patients continue to enjoy life? Carly Ornstein shares how to manage symptoms, find a treatment goal, and get the right care.Get email alerts | http://www.pat...... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances
This is a very exciting time for multiple myeloma (MM) research, with advances in a range of areas from new endpoints, to novel therapies and imaging. In this video, an overview of these updates are g... Author: VJHemOnc Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Why use model systems for multiple myeloma research?
Model systems, including patient specimens and murine organisms, are very important for multiple myeloma (MM) research. Speaking from the Myeloma 2017 meeting in Edinburgh, UK, Larry Boise, PhD, from ... Author: VJHemOnc Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

The future of immunotherapy in multiple myeloma
There is a plethora of therapies available for multiple myeloma (MM). In this insightful panel discussion at the Myeloma 2017 meeting in Edinburgh, UK, Ivan Marques Borrello, MD from John Hopkins Scho... Author: VJHemOnc Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Novel therapeutics in multiple myeloma
There are currently many exciting novel therapeutics and combination therapies undergoing clinical trials for use in multiple myeloma (MM) patients. These are explored in an intriguing panel discussio... Author: VJHemOnc Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

An E-learning tool for hematology-oncology nurses
A key finding of a recent Bloodwise study into the specific needs of hematological cancer patients highlighted the importance of access to a Clinical Nurse Specialist (CNS). However, with busy wards a... Author: VJHemOnc Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

The importance of cancer nursing educators
Cancer nursing is facing a number of challenges, including the increasing complexity of treatments. In this interview, Mary Tanay of Kings College London, London, UK, passionately discusses how educa... Author: VJOncology Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

A study of chemotherapy-induced peripheral neuropathy: the experiences and support needs of women following cancer treatment
When patients first receive a cancer diagnosis and go through treatment, they can be overwhelmed, and thus unprepared for the side effects that can occur during and even after treatment has ceased. In... Author: VJOncology Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Curbing cancer patients expectations of immunotherapy
Immunotherapy is a growing treatment area for cancer, with a lot of hype in the mainstream media. In this interview, recorded at the UK Oncology Nursing Society (UKONS) Annual Conference 2017, held in... Author: VJOncology Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

The adapting role of the cancer nurse: immunotherapy
Immunotherapy has received a lot of coverage as a revolutionary cancer treatment, in both the medical community and in the mainstream media, and it is likely that this trend will continue in the comin... Author: VJOncology Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Nurses and the growth of personalized cancer care
In recent years, molecular tests have emerged that can help provide information about cancers, such as determining what type of therapy is likely to be most effective. In this interview, Elaine Vicker... Author: VJOncology Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

MRI before prostate biopsy? - NO
Dr. Jochen Walz discusses his opposition to the use of MRIs before biopsies for prostate cancer. Author: vhsimons Added: 12/10/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 10, 2017 Category: Cancer & Oncology Source Type: podcasts

MRI before prostate biopsy? - Yes!
Dr. Harriet Theony discusses the concept of Higher definition MRIs in determining the need for prostate biopsies Author: vhsimons Added: 12/10/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 10, 2017 Category: Cancer & Oncology Source Type: podcasts

New Target & amp; Treatment in Advanced NSCLC: Dabrafenib/Trametinib for BRAF V600E Mutation-Positive NSCLC (BMIC-018)
Dr. Jack West reviews data on the FDA-approved combination of dabrafenib/trametinib for patients with BRAF V600E mutation-positive advanced NSCLC, as published by Planchard & colleagues in Lancet ... Author: BeaconMedIC Added: 12/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 8, 2017 Category: Cancer & Oncology Source Type: podcasts

Reducing late symptom reporting: a holistic approach in cancer nursing
It is critical that cancer patients report the side effects of their treatments, whether chemotherapy or immunotherapy, as early as possible to avoid the worsening of illness and further complications... Author: VJOncology Added: 12/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 8, 2017 Category: Cancer & Oncology Source Type: podcasts

The role of the nurse in elderly cancer patient care
Elderly cancer patients tend to have more complex conditions, and therefore require a strong support system to assist their needs and queries. Speaking from the UK Oncology Nursing Society (UKONS) Ann... Author: VJOncology Added: 12/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 8, 2017 Category: Cancer & Oncology Source Type: podcasts

Person-centered care and the elderly cancer patient: an important issue
With age being the biggest risk factor for cancer, and an ageing population in the UK, the NHS is having to treat an increasing number of elderly cancer patients who are living for longer. In this int... Author: VJOncology Added: 12/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 8, 2017 Category: Cancer & Oncology Source Type: podcasts